Vimarsana
Biggest News Aggregation in the World

Page 46 - Breakthrough Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Device Today - Breaking & Trending Today

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update - Vimarsana News

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life...

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022 - Vimarsana News

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today...

LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started - Vimarsana News

LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started

Munster, [Germany], July 30 (ANI/PRNewswire): LIMES (Prospective Multi-Center Randomized Controlled Trial to Evaluate the Safety and Efficacy of SiroLIMus Drug-Coated Balloon versus Standard Angioplasty for the Treatment of Infrapopliteal Occlusions in Patients with PEripheral Arterial DiSease) has already enrolled 15 patients, which is encouraging as the Company looks to take a leap in the peripheral artery disease (PAD) treatment. Initiated by the University Hospitals Jena and Leipzig in Germany and led by Principal Investigator (PI) Prof. Dr Ulf Teichgraber alongside Co-PI Prof. Thomas Zell...

Related Topics:
United StatesThomas ZellerNassan MalyarUlf TeichgraberDierk ScheinertUniversity Hospital MunsterConcept Medical IncUniversity Hospitals JenaDrug AdministrationDrug Coated BalloonStandard AngioplastyInfrapopliteal OcclusionsArterial DiseasePrincipal InvestigatorMagic TouchPlain Old Balloon AngioplastyBreakthrough DeviceCoated BalloonBreakthrough Device DesignationUly 30 Ani Prnewswire Limes Prospective Multi Center Randomized Controlled Trial To Evaluate The Safety And Efficacy Of Sirolimus Drug Coated Balloon Versus Standard Angioplasty For Treatment Infrapopliteal Occlusions In Patients With Peripheral Arterial Disease Has Already Enrolled 15Hich Is Encouraging As The Company Looks To Takea Leap In Peripheral Artery Disease Pad Treatment Initiated By University Hospitals Jena And Leipzig Germany Led Principal Investigator Pi Prof Dr Ulf Teichgraber Alongside Co Thomas Zeller Dierk ScheinertImes Isa ProspectiveAndomized Controlled Trial Rct Which Is Designed And Aimed To Evaluate Magic Touch Pta 0 014 Quot 018 Concept Medical Inc Versus Poba Plain Old Balloon Angioplasty Ina Head Comparison 1 The Kicked Off With Index Patient Enrolled On 31st March 2022 By Pd Dr Nassan Malyar At University Hospital Munster In Germany Limes Set Enrol 230 PatientsAndomized In 1 Magic Touch Pta Poba Fashion Currently 19 Centres Across Germany And Austria The Patient Population Will Include Patients Presenting With Documented Chronic Critical Limb Ischemia Cli Target Defined As Rutherford Clinical Category Rcc 4O Lesion Length Limitation And No In Number Of Used Devices Follow Up Will Be Per House Visits At 30 Days
Concept Medical Inc.: LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started - Vimarsana News

Concept Medical Inc.: LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started

Concept Medical Inc., a pioneer in developing drug delivery device platforms for vascular intervention, has announced the initiation of LIMES trial. MÜNSTER, Germany, July 29, 2022 /PRNewswire/

LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started - Vimarsana News

LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started

/PRNewswire/ -- LIMES (Prospective Multi-Center Randomized Controlled Trial to Evaluate the Safety and Efficacy of SiroLIMus Drug Coated Balloon versus...